Skip to content
Angio Dynamics
  • Products
  • Patients
  • Healthcare Professionals
  • About Angiodynamics
  • Investors
  • News & Events
  • Careers
  • Research
  • Contact Us
  • Home
  • About Angiodynamics
  • Investors
  • News & Events
  • Careers
  • Research
  • Contact Us
Angiodynamics
  • Products
    • By Product Category
    • By Division
    • By Brand List
  • Patient
    • Patient Stories
    • Patient Resources
  • Healthcare Professionals
Home / News & Events / Announcements

Announcements

  • All
  • Announcements
  • Events
  • Investors

AngioDynamics Announces First Patient Enrolled in APEX-AV Study Assessing AlphaVac F18⁸⁵ PE System in Treatment of Pulmonary Embolism

October 31st, 2022 Announcements

AngioDynamics Announces FDA Clearance of Expanded Indications for Auryon Atherectomy System

August 5th, 2022 Announcements

AngioDynamics, The PERT Consortium™ Launch APEX-AV Study Assessing AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE System in Treatment of Pulmonary Embolism

April 28th, 2022 Announcements

New Clinical Study to Assess Auryon Atherectomy Treatment in Below-the-Knee Arteries

April 14th, 2022 Announcements

First Patients Treated in PRESERVE Clinical Study

April 14th, 2022 Announcements

AngioDynamics to Present at the Needham Virtual Growth Conference

January 6th, 2022 Announcements

AngioDynamics to Report Fiscal 2022 Second Quarter Financial Results on January 6, 2022

December 15th, 2021 Announcements

AngioDynamics Reports Fiscal 2022 First Quarter Financial Results; Updates Guidance

September 30th, 2021 Announcements

AngioDynamics to Report Fiscal 2022 First Quarter Financial Results on September 30, 2021

September 15th, 2021 Announcements

New AMA Category III CPT Code Issued for Transcatheter Removal/Debulking of Intracardiac Masses

August 30th, 2021 Announcements

AngioDynamics Receives FDA Approval for PRESERVE Study

August 12th, 2021 Announcements

AngioDynamics to Present at the Canaccord Genuity Virtual Growth Conference

July 29th, 2021 Announcements

AngioDynamics Reports Fiscal 2021 Fourth Quarter and Full-Year Financial Results

July 13th, 2021 Announcements

AngioDynamics Announces Details for Investor & Technology Day on July 13, 2021

July 8th, 2021 Announcements

AngioDynamics to Report Fiscal 2021 Fourth Quarter and Full-Year Financial Results and Host Investor & Technology Day on July 13, 2021

June 24th, 2021 Announcements

AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System

June 8th, 2021 Announcements

AngioDynamics to Present at the UBS Virtual Global Healthcare Conference

May 17th, 2021 Announcements

AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System

April 12th, 2021 Announcements

AngioDynamics to Present at the Needham Virtual Healthcare Conference

April 5th, 2021 Announcements

AngioDynamics Reports Fiscal 2021 Third Quarter Financial Results and Updates Guidance

March 30th, 2021 Announcements

AngioDynamics to Participate in a Virtual Fireside Chat at the KeyBanc Life Sciences & MedTech Investor Forum

March 15th, 2021 Announcements

AngioDynamics to Participate in a Virtual Fireside Chat at the Oppenheimer Healthcare Conference

March 9th, 2021 Announcements

Using AI to Predict Clinical Trial Success

February 10th, 2021 Announcements

AngioDynamics Appoints Richard C. Rosenzweig Senior Vice President, General Counsel and Secretary, Promotes Juan Carlos Serna to Senior Vice President, Scientific & Clinical Affairs

February 1st, 2021 Announcements

AngioDynamics Reports Fiscal 2021 Second Quarter Financial Results

January 7th, 2021 Announcements

AngioDynamics to Present at the J.P. Morgan Virtual Healthcare Conference

January 4th, 2021 Announcements

AngioDynamics to Present at the Needham Virtual Growth Conference

December 29th, 2020 Announcements

AngioDynamics Announces Presentation of Positive Safety, Efficacy Results from RAPID Outcomes Database

November 12th, 2020 Announcements

AngioDynamics Reports Fiscal 2021 First Quarter Financial Results

September 29th, 2020 Announcements

AngioDynamics Announces Commercial Launch of Auryon Atherectomy System in United States

September 21st, 2020 Announcements

AngioDynamics to Report Fiscal 2021 First Quarter Financial Results on September 29, 2020

September 17th, 2020 Announcements

AngioDynamics Announces First Patient Enrolled in PATHFINDER I Registry Examining Long-Term Effectiveness and Safety of Auryon Atherectomy System

August 17th, 2020 Announcements

AngioDynamics to Participate in a Virtual Fireside Chat at the Canaccord Genuity Growth Conference

August 3rd, 2020 Announcements

AngioDynamics Receives FDA Clearance and CE Mark for SmartPort+ Implantable Port

July 27th, 2020 Announcements

AngioDynamics’ Response to the Coronavirus (COVID-19) Outbreak

July 21st, 2020 Announcements

AngioDynamics Reports Fiscal 2020 Fourth Quarter and Full-Year Financial Results

July 16th, 2020 Announcements

AngioDynamics to Report Fiscal 2020 Fourth Quarter and Full-Year Financial Results on July 16, 2020

June 23rd, 2020 Announcements

AngioDynamics to Participate in a Virtual Fireside Chat at the Raymond James Human Health Innovation Conference

June 8th, 2020 Announcements

AngioDynamics to Present at the UBS Virtual Global Healthcare Conference

May 7th, 2020 Announcements

AngioDynamics Reports Fiscal 2020 Third Quarter Financial Results

April 7th, 2020 Announcements

AngioDynamics to Report Fiscal 2020 Third Quarter Financial Results on April 7, 2020

March 10th, 2020 Announcements

AngioDynamics to Present at Two Investor Conferences in March

February 27th, 2020 Announcements

AngioDynamics Appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer

February 6th, 2020 Announcements

AngioDynamics Launches PATHFINDER I Registry to Evaluate Performance and Clinical Outcomes of the AURYON™ Atherectomy System

January 16th, 2020 Announcements

AngioDynamics Reports Fiscal 2020 Second Quarter Financial Results

January 7th, 2020 Announcements

AngioDynamics to Present at the J.P. Morgan Healthcare Conference

January 6th, 2020 Announcements

AngioDynamics to Report Fiscal 2020 Second Quarter Financial Results on January 7, 2020

December 10th, 2019 Announcements

AngioDynamics Hosts “Beacon of Hope” Event to Mark Pancreatic Cancer Awareness Month

November 5th, 2019 Announcements

AngioDynamics Acquires Eximo Medical, Ltd. and its Innovative 355nm Laser Atherectomy Technology

October 3rd, 2019 Announcements

AngioDynamics Reports Fiscal 2020 First Quarter Financial Results

October 3rd, 2019 Announcements

AngioDynamics Awarded Premier’s Nationally Outsourced Implantable Infusion Port Agreement

September 9th, 2019 Announcements

AngioDynamics to Report Fiscal 2020 First Quarter Financial Results on October 3, 2019

September 5th, 2019 Announcements

AngioDynamics Announces Appointment of Former Johnson & Johnson Executive Karen Licitra to its Board of Directors

July 31st, 2019 Announcements

AngioDynamics to Present at the Canaccord Genuity Growth Conference

July 23rd, 2019 Announcements

AngioDynamics Reports Fiscal 2019 Fourth Quarter and Full-Year Financial Results

July 10th, 2019 Announcements

AngioDynamics to Report Fiscal 2019 Fourth Quarter and Full-Year Financial Results on July 10, 2019

June 20th, 2019 Announcements

AngioDynamics to Present at the Raymond James Life Sciences and MedTech Conference

June 4th, 2019 Announcements

AngioDynamics Completes Sale of NAMIC® Fluid Management Portfolio to Medline Industries, Inc.

June 3rd, 2019 Announcements

AngioDynamics to Ring NASDAQ Closing Bell to Celebrate the 15th Anniversary of its Listing on the Exchange

May 28th, 2019 Announcements

AngioDynamics Receives FDA Approval to Initiate Pilot Study for the Use of NanoKnife® to Treat Prostate Cancer

May 22nd, 2019 Announcements

AngioDynamics Announces First Patient Enrolled in NanoKnife® DIRECT Clinical Study for the Treatment of Stage III Pancreatic Cancer

May 13th, 2019 Announcements

AngioDynamics Announces Agreement to Sell NAMIC® Fluid Management Business to Medline Industries, Inc. for $167.5 Million

April 17th, 2019 Announcements

AngioDynamics’ DIRECT Clinical Study Receives Institutional Review Board Approval for the Treatment of Stage III Pancreatic Cancer

April 17th, 2019 Announcements

AngioDynamics Reports Fiscal 2019 Third Quarter Financial Results

April 2nd, 2019 Announcements

AngioDynamics to Present at the Needham Healthcare Conference

April 1st, 2019 Announcements

AngioDynamics Receives FDA Approval to Initiate NanoKnife® DIRECT Clinical Study for the Treatment of Stage III Pancreatic Cancer

April 1st, 2019 Announcements

OARtrac® Radiation Dose Monitoring System Receives Expanded FDA Clearance for Electron Radiation Therapy

March 28th, 2019 Announcements

AngioDynamics to Report Fiscal 2019 Third Quarter Financial Results on April 2, 2019

March 12th, 2019 Announcements

AngioDynamics Wins Patent Infringement Dispute With Bard

March 8th, 2019 Announcements

AngioDynamics to Present at the Barclays Global Healthcare Conference

February 26th, 2019 Announcements

AngioDynamics Reports Fiscal 2019 Second Quarter Financial Results

January 4th, 2019 Announcements

AngioDynamics to Present at the J.P. Morgan Healthcare Conference

December 20th, 2018 Announcements

AngioDynamics to Report Fiscal 2019 Second Quarter Financial Results on January 4, 2019

December 10th, 2018 Announcements

AngioDynamics Reports Fiscal 2019 First Quarter Financial Results

September 27th, 2018 Announcements

AngioDynamics to Present at the Cantor Global Healthcare Conference

September 19th, 2018 Announcements

AngioDynamics to Acquire RadiaDyne and its Revolutionary OARtrac® Radiation Dose Monitoring Platform to Further Expand Oncology Portfolio

September 13th, 2018 Announcements

AngioDynamics to Report Fiscal 2019 First Quarter Financial Results on September 27, 2018

September 13th, 2018 Announcements

AngioDynamics to Present at Two Investor Conferences in September

August 23rd, 2018 Announcements

AngioDynamics Provides Updates on Oncology and Vascular Access Businesses

August 15th, 2018 Announcements

AngioDynamics to Report Fiscal 2018 Fourth Quarter and Full-Year Financial Results on July 11, 2018

June 21st, 2018 Announcements
Angio Dynamics

GLOBAL CUSTOMER SERVICE:

800-772-6446 (OPT 2)
11AM – 1AM CET | 5AM – 7PM EST
MONDAY – FRIDAY

Contact Us

Quick Links
  • Research
  • Intellectual Property
  • Leadership
  • Investors
  • Careers
  • Contact Us
Our Products
VenaCure 1470 Pro
Connect with Us Facebook Twitter Linkedin Medium

© 2023 AngioDynamics. All rights reserved.

  • Privacy Statement
  • Terms of Use

Website Design by Spiral Design | Website Development by Mannix Marketing, Inc.